Residential treatment and medication treatment for opioid use disorder: The role of state Medicaid innovations in advancing the field

Background: Mortality due to opioid use continues to increase; effective strategies to improve access to treatment for opioid use disorder (OUD) are needed. While OUD medications exist, they are used infrequently and often not available in residential addiction treatment settings. CMS provides expan...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Peggy L. O'Brien, Maureen T. Stewart, Morgan C. Shields, Mackenzie White, Joel Dubenitz, Judith Dey, Norah Mulvaney-Day
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Elsevier 2022-09-01
Serie:	Drug and Alcohol Dependence Reports
Soggetti:	Residential substance use treatment Medication for opioid use disorder Medicaid 1115(a) waiver Opioid use disorder Buprenorphine
Accesso online:	http://www.sciencedirect.com/science/article/pii/S2772724622000622
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!